Related Experiment Videos
Salazopyrin-induced eosinophilic pneumonia
Respiration; International Review of Thoracic Diseases
|January 1, 1980
Summary
A patient experienced eosinophilic pneumonia and other side effects from Salazopyrin treatment for ulcerative colitis. Symptoms resolved upon drug discontinuation and recurred upon reintroduction, indicating a causal link.
Area of Science:
- Gastroenterology
- Pulmonology
- Dermatology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Salazopyrin (sulfasalazine) is a common treatment for UC.
- Adverse drug reactions can complicate UC management.
Purpose of the Study:
- To report a case of eosinophilic pneumonia and other adverse effects associated with Salazopyrin in a UC patient.
- To investigate the relationship between Salazopyrin administration and the observed side effects.
Main Methods:
- Clinical case observation.
- Drug challenge and dechallenge (reintroduction and discontinuation).
- Symptom monitoring.
Main Results:
- The patient developed eosinophilic pneumonia, sinus tachycardia, skin rashes, headache, and insomnia after starting Salazopyrin.
- All symptoms resolved spontaneously after discontinuing Salazopyrin.
- Symptoms reappeared upon readministration of Salazopyrin, confirming drug causality.
Conclusions:
- Salazopyrin can cause serious adverse effects, including eosinophilic pneumonia, in patients with ulcerative colitis.
- Careful monitoring for side effects is crucial during Salazopyrin therapy.
- Drug-induced adverse events necessitate prompt evaluation and management.